SCHEMBL29958569

SCHEMBL29958569

Oc1ccc(C=Cc2cc(O)c(O)c(O)c2)cc1O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.81
KDM4E B2RXH2 4/20 0.72
ALOX5 P09917 3/20 0.72
CYP3A4 P08684 3/20 0.72
ALDH1A1 P00352 3/20 0.72
HSD17B10 Q99714 3/20 0.72
ALOX12 P18054 2/20 0.72
CYP2C9 P11712 2/20 0.72
HIF1A Q16665 2/20 0.72
MEN1 O00255 2/20 0.72
LMNA P02545 2/20 0.72
TTR P02766 2/20 0.72
POLB P06746 2/20 0.72
MMP2 P08253 2/20 0.72
MAPT P10636 2/20 0.72
THRB P10828 2/20 0.72
MMP9 P14780 2/20 0.72
HPGD P15428 2/20 0.72
PMP22 Q01453 2/20 0.72
KMT2A Q03164 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607871 1.00 LCK (0.81) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL4607867 1.00 LCK (0.81) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL30631591 0.90 LCK (1.00) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL31706727 0.90 LCK (1.00) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL1824175 0.90 LCK (1.00) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL1824176 0.90 LCK (1.00) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL10335571 0.87 LCK (0.94) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL4608757 0.84 PTGS2 (0.54) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL4608754 0.84 PTGS2 (0.54) LCKKDM4EALOX5CYP3A4ALDH1A1
SCHEMBL1932873 0.84 LCK (0.91) LCKKDM4EALOX5CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313010-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 Szekeres, Thomas (AT) 2024-02-07 EP claimed
WO-2022200086-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 SZEKERES THOMAS (AT) 2022-09-29 WO claimed
EP-4313010-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 Szekeres, Thomas (AT) 2024-02-07 EP disclosed
WO-2022200086-A1 COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF COVID- 19 SZEKERES THOMAS (AT) 2022-09-29 WO disclosed